Option Care Health (NASDAQ:OPCH) Given New $40.00 Price Target at JPMorgan Chase & Co.

Option Care Health (NASDAQ:OPCH) had its price objective boosted by JPMorgan Chase & Co. from $38.00 to $40.00 in a report published on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Several other research firms have also recently weighed in on OPCH. Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research increased their price objective on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Price Performance

Shares of OPCH stock opened at $30.33 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $5.16 billion, a P/E ratio of 25.49, a P/E/G ratio of 2.11 and a beta of 1.31. The business’s 50 day moving average price is $24.26 and its 200-day moving average price is $27.80. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now owns 326,334 shares in the company, valued at approximately $7,355,568.36. This represents a 15.18 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

Hedge funds have recently added to or reduced their stakes in the company. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares in the last quarter. GAMMA Investing LLC increased its holdings in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares in the last quarter. Lindenwold Advisors INC increased its holdings in Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock worth $299,000 after buying an additional 489 shares in the last quarter. Pacer Advisors Inc. raised its position in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after buying an additional 537 shares during the last quarter. Finally, Sheets Smith Wealth Management lifted its stake in Option Care Health by 2.4% during the 4th quarter. Sheets Smith Wealth Management now owns 23,856 shares of the company’s stock valued at $553,000 after acquiring an additional 550 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.